Comparative Effects of Laser and Extracorpeal Shock Wave in Patients With Achilles Tendinopathy.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 15, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatments for Achilles tendinopathy, a painful condition that affects the tendon at the back of your ankle. The study aims to compare the effects of laser therapy and extracorporeal shock wave therapy on patients who have been diagnosed with chronic Achilles tendinopathy. This condition can make it hard to walk, run, or participate in other physical activities, and effective treatment is important for recovery.
To join the study, participants need to be between 18 and 40 years old and have a confirmed diagnosis of chronic Achilles tendinopathy, with a pain score of more than 2 on a scale of 0 to 10. However, individuals with certain medical conditions or those who have had specific treatments for their tendon pain may not be eligible. If you qualify and decide to participate, you can expect to receive one of the two treatments and help contribute to finding the best way to manage this common condition. The trial is not yet recruiting participants, but it's an important step toward improving treatment options for Achilles tendinopathy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of patients 18-40.
- • Diagnosed with chronic Achillis tendinopathy and NPRS rating more than 2.
- • Both male and female.
- • Patient must be diagnosed with Achillis Tendinopathy by single leg raise or Thompson test.
- Exclusion Criteria:
- • contraindications to LLLT to the area of the Achilles tendon.
- • comorbid musculoskeletal or serious conditions that may have confounded treatment or anticipated recovery .
- • nonsteroidal anti-inflammatory drug use steroid injections or surgery for the condition; insertional tendinopathy or bursitis (retrocalcaneal or Achilles; determined by clinical examination.
- • neurologic signs; and adverse neural tension affecting the sciatic or sural nerve.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muzna Munir, PhD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported